Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.45% | -154.41% | -76.30% | -111.74% | -94.79% |
| Total Depreciation and Amortization | 12.88% | 21.52% | 24.28% | 113.38% | 216.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.10% | 113.73% | 81.69% | 47.17% | 13.01% |
| Change in Net Operating Assets | 10.85% | 134.70% | -90.07% | -141.72% | 202.98% |
| Cash from Operations | 172.68% | 55.19% | -101.82% | -156.35% | 60.01% |
| Capital Expenditure | -85.12% | -843.50% | -36.23% | -69.52% | 18.06% |
| Sale of Property, Plant, and Equipment | 0.00% | 533.33% | 320.00% | 182.86% | 400.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.49% | 56.85% | -21.83% | 96.13% | -448.10% |
| Total Debt Issued | 14.58% | 40.88% | 72.66% | 41.64% | 30.92% |
| Total Debt Repaid | -18.82% | -31.24% | -55.00% | -46.94% | -49.41% |
| Issuance of Common Stock | -- | -68.10% | -- | -- | -100.00% |
| Repurchase of Common Stock | 52.11% | 21.85% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.38% | 508.91% | -193.44% | -990.00% | -- |
| Cash from Financing | -362.77% | -58.63% | 229.44% | 13.35% | -94.21% |
| Foreign Exchange rate Adjustments | -241.56% | 139.62% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.39% | -62.61% | 188.77% | 91.40% | -197.31% |
